Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Care of the patient with strabismus: Esotropia and exotropia.

BIBLIOGRAPHIC SOURCE(S)

  • American Optometric Association. Care of the patient with strabismus: esotropia and exotropia. 2nd ed. St. Louis (MO): American Optometric Association; 1996. 69 p. (Optometric clinical practice guideline; no. 16). [115 references]

GUIDELINE STATUS

This is the current release of the guideline.

According to the guideline developer, this guideline has been reviewed on a biannual basis and is considered to be current as of 2004. This review process involves updated literature searches of electronic databases and expert panel review of new evidence that has emerged since the original publication date.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Diagnosis of Strabismus

The examination of strabismic patients generally includes all areas of the evaluation of a comprehensive adult or pediatric eye and vision examination. The evaluation of sensory, motor, refractive, and accommodative functions requires further, in-depth examination. Additional office visits may be required to complete the examination process, especially with younger children.

The evaluation of a patient with strabismus may include, but is not limited to, the following components. Professional judgment and individual patient symptoms and findings may have significant impact on the nature, extent, and course of the services provided.

  1. Patient History
  2. Ocular Examination
    1. Visual Acuity
    2. Ocular Motor Deviation
    3. Monocular Fixation
    4. Extraocular Muscle Function
    5. Sensorimotor Fusion
    6. Accommodation
    7. Refraction
    8. Ocular Health Assessment and Systemic Health Screening

Management of Strabismus

The extent to which an optometrist can provide treatment for strabismus may vary depending on the state's scope of practice laws and regulations and the individual optometrist's certification. Management of the patient with strabismus may require consultation with or referral to an ophthalmologist for those services outside the optometrist's scope of practice.

The management of the strabismic patient is based on the interpretation and analysis of the examination results and overall evaluation. The goals of treatment may include (1) obtaining normal visual acuity in each eye, (2) obtaining and/or improving fusion, (3) eliminating any associated sensory adaptations, and (4) obtaining a favorable functional appearance of the alignment of the eyes. The significance of normal ocular alignment for the development of a positive self-image and interpersonal eye contact cannot be overemphasized.

The indications for and specific types of treatment need to be individualized for each patient.

The treatment of strabismus may include any or all of the following procedures:

  1. Optical Correction
  2. Added Lens Power
  3. Prisms
  4. Active Vision Therapy
  5. Pharmacological Agents
  6. Extraocular Muscle Surgery
  7. Chemodenervation

Patient Education

The prognosis, advantages, and disadvantages of the various modes of treatment should be discussed with the patient and/or the patient's parents and a plan developed based on this dialogue.

Prognosis and Follow-up

The purpose of the follow-up evaluation is to assess the patient's response to therapy and to alter or adjust treatment as needed.

The frequency and composition of evaluation and management visits for esotropia and exotropia are summarized in the following table:

Frequency and Composition of Evaluation and Management Visits for Esotropia and Exotropia


Type of Patient Number of Evaluation Visits Treatment Options Frequency of Follow-Up Visits* Management Plan

Accommodative esotropia 1 to 3
  • Optical correction
  • Vision therapy
  • <6 years: every 4 to 6 mos
  • 6 to 10 years: every 6 to 12 mos
  • >11 years: every 12 mos
Provide refractive correction; treat any amblyopia; use added plus at near if needed to facilitate fusion; prescribe vision therapy to develop/enhance normal sensory and motor fusion.
Acute esotropia and exotropia 1 to 3
  • Prisms
  • Vision therapy
  • Surgery
  • Every 3 to 12 mos
Use prisms to eliminate diplopia and re-establish binocular vision; prescribe vision therapy; in stable deviations over 20 to 25 prism diopter (PD), consult with ophthalmologist regarding extraocular muscle surgery.
Consecutive esotropia and exotropia 1 to 3
  • Optical correction
  • Prisms
  • Vision therapy
  • Surgery
  • Variable, depending on etiology
Provide refractive correction; prescribe prism and/or vision therapy to prevent amblyopia, eliminate diplopia, and establish normal sensory fusion, if applicable.
Infantile or early-acquired esotropia and exotropia 1 to 3
  • Optical correction
  • Prisms
  • Vision therapy
  • Surgery
  • <2 years: every 3 mos
  • 2 to 5 years: every 4 to 6 mos
  • 6 to 10 years: every 12 mos
  • >11 years: every 12 to 24 mos
Provide refractive correction; treat any amblyopia; use prism to establish normal sensory fusion, if applicable; consult with ophthalmologist regarding extraocular muscle surgery.
Intermittent exotropia 1 to 3
  • Optical correction
  • Prisms
  • Vision therapy
  • Surgery
  • <5 years: every 4 to 6 mos
  • 5 to 10 years: every 6 to 12 mos
  • >11 years: every 12 to 24 mos
Provide refractive correction; use added minus lens power or base-in prism if needed to facilitate fusion; prescribe vision therapy; if deviation persists or increases, consult with ophthalmologist regarding extraocular muscle surgery.
Mechanical esotropia and exotropia 1 to 3
  • Prisms
  • Surgery
  • Variable, depending on etiology
No therapy if strabismus is not present in the primary position of gaze and no diplopia. Consider prisms and/or surgery to treat head turn.
Microtropia 1 to 3
  • Optical correction
  • Prisms
  • Vision therapy
  • Every 3 to 12 mos
Provide refractive correction; treat any amblyopia; prescribe vision therapy and/or prism to establish bifoveal fusion, if applicable.
Sensory esotropia and exotropia 1 to 3
  • Optical correction
  • Prisms
  • Vision therapy
  • Surgery
  • Every 3 to 12 mos
Consult with ophthalmologist regarding treatment of any underlying ophthalmic disease; provide refractive correction; treat any amblyopia; prescribe vision therapy and/or prism, if applicable; if deviation persists or increases, consult with ophthalmologist regarding extraocular muscle surgery.

* Vision therapy would require additional visits.

CLINICAL ALGORITHM(S)

An algorithm is provided for Optometric Management of the Patient with Strabismus.

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is not specifically stated for each recommendation.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • American Optometric Association. Care of the patient with strabismus: esotropia and exotropia. 2nd ed. St. Louis (MO): American Optometric Association; 1996. 69 p. (Optometric clinical practice guideline; no. 16). [115 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1995 (revised 1999; reviewed 2004)

GUIDELINE DEVELOPER(S)

American Optometric Association - Professional Association

SOURCE(S) OF FUNDING

Funding was provided by the Vision Service Plan (Rancho Cordova, California) and its subsidiary Altair Eyewear (Rancho Cordova, California)

GUIDELINE COMMITTEE

American Optometric Association Consensus Panel on the Care of the Patient with Strabismus

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Members: Robert P. Rutstein, O.D. (Principal Author); Martin S. Cogen, M.D.; Susan A. Cotter, O.D.; Kent M. Daum, O.D., Ph.D.; Rochelle L. Mozlin, O.D.; Julie M. Ryan, O.D.

AOA Clinical Guidelines Coordinating Committee Members: John F. Amos, O.D., M.S. (Chair); Barry Barresi, O.D., Ph.D.; Kerry L. Beebe, O.D.; Jerry Cavallerano, O.D., Ph.D.; John Lahr, O.D.; David Mills, O.D.

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

According to the guideline developer, this guideline has been reviewed on a biannual basis and is considered to be current as of 2004. This review process involves updated literature searches of electronic databases and expert panel review of new evidence that has emerged since the original publication date.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American Optometric Association Web site.

Print copies: Available from the American Optometric Association, 243 N. Lindbergh Blvd., St. Louis, MO 63141-7881

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

The following is available:

  • Answers to your questions about strabismus. St. Louis, MO: American Optometric Association. (Patient information pamphet).

Print copies: Available from the American Optometric Association, 243 N. Lindbergh Blvd., St. Louis, MO 63141-7881; Web site, www.aoanet.org.

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This summary was completed by ECRI on December 1, 1999. The information was verified by the guideline developer on January 31, 2000.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo